home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

10 rows where docket_id = "FDA-2006-E-0439" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 4

  • 2007 4
  • 2006 3
  • 2008 2
  • 2009 1

document_type 2

  • Other 9
  • Notice 1

agency_id 1

  • FDA 10
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-E-0439-0010 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Notice of Final Determination from U.S. Patent and Trademark Office to Novo Nordisk Inc. Other Letter(s) 2009-02-04T05:00:00Z 2009 2 2009-02-04T05:00:00Z   2026-01-08T01:26:35Z   0 0 0900006480838fa3
FDA-2006-E-0439-0009 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Certificate Extending Patent Term from U.S. Patent and Trademark Office to Novo Nordisk Inc. Other Certificate Extending Patent Term 2008-11-05T05:00:00Z 2008 11 2008-11-05T05:00:00Z   2026-01-08T01:20:40Z   0 0 09000064806acad6
FDA-2006-E-0439-0008 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Application for Patent Term Extension from Novo Nordisk Inc. Other Application 2008-11-05T05:00:00Z 2008 11 2008-11-05T05:00:00Z   2026-01-08T01:18:25Z   0 0 0900006480461eba
FDA-2006-E-0439-0007 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2007-10-24T04:00:00Z 2007 10     2026-01-08T01:15:09Z   0 0 0900006480461ec7
FDA-2006-E-0439-0006 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Determination of Regulatory Review Period for Purposes of Patent Extension; NOVOLOG Notice General Notice 2007-03-26T04:00:00Z 2007 3 2007-03-26T04:00:00Z   2026-01-08T01:13:19Z E7-5445 0 0 0900006480461ec5
FDA-2006-E-0439-0005 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2007-03-13T04:00:00Z 2007 3     2026-01-08T01:08:45Z   0 0 0900006480461ec3
FDA-2006-E-0439-0004 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2007-01-25T05:00:00Z 2007 1     2026-01-08T00:53:42Z   0 0 0900006480461ec2
FDA-2006-E-0439-0003 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2006-12-12T05:00:00Z 2006 12     2026-01-08T00:50:31Z   0 0 0900006480461ec1
FDA-2006-E-0439-0001 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2006-11-29T05:00:00Z 2006 11     2026-01-08T00:43:18Z   0 0 0900006480461ea5
FDA-2006-E-0439-0002 FDA Patent Extension Application for NovoLog insulin aspart (rDNA origin) injection, U.S. Patent No. 5,618,913 FDA-2006-E-0439 Notice Regarding Associate Power of Attorney from U.S. Patent and Trademark Office to Novo Nordisk Inc. Other Letter(s) 2006-11-29T05:00:00Z 2006 11     2026-01-08T00:46:32Z   0 0 0900006480461ebf

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
Powered by Datasette · Queries took 653.7ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API